Differential inhibition of group IVA and group VIA phospholipases A 2 by 2-oxoamides

Journal of Medicinal Chemistry

Volumn 49, Issue 9, 2006, Pages 2821-2828

  Stephens, Daren ^a   Barbayianni, Efrosini ^b   Constantinou Kokotou, Violetta ^c   Peristeraki, Anna ^c   Six, David A ^a   Cooper, Jennifer ^a   Harkewicz, Richard ^a   Deems, Raymond A ^a   Dennis, Edward A ^a   Kokotos, George ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF ATHENS   (Greece)

^c AGRICULTURAL UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

2 OXOAMIDE INHIBITOR; AMIDE; CARBOXYLIC ACID DERIVATIVE; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 GROUP IVA; PHOSPHOLIPASE A2 GROUP VIA; PHOSPHOLIPASE A2 INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; ENZYME INHIBITION; INFLAMMATION; MOUSE; NONHUMAN; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

ANIMALS; CELL LINE; DINOPROSTONE; ENZYME INHIBITORS; MICE; MOLECULAR STRUCTURE; PHOSPHOLIPASES A; PYRIDINES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33646461525     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm050993h     Document Type: Article

References (48)

1. 2 and their effect on enzyme activity. J. Biol. Chem. 1998, 273, 207-214.
2. 1 macrophages. Proc. Natl. Acad. Sci. U.S.A. 1995, 92, 8527-8531.
3. 1 macrophages. J. Biol. Chem. 1997, 272, 29317-29321.
4. 2. J. Biol. Chem. 1997, 272, 16069-16072.
5. 2 in fatty acid incorporation, phospholipid remodeling, lysophosphatidylcholine generation, and secretagogue-induced arachidonic acid release in pancreatic islets and insulinoma cells. J. Biol. Chem. 1999, 274, 13915-13927.
6. 2 in uterine stromal cell phospholipid remodelling. Eur. J. Biochem. 2000, 267, 7118-7127.
7. Ma, Z.; Bohrer, A.; Wohltmann, M.; Ramanadham, S.; Hsu, F. F.; Turk, J. Studies of phospholipid metabolism, proliferation, and secretion of stably transfected insulinoma cells that overexpress group VIA phospholipase A(2). Lipids 2001, 36, 689-700.
8. Ma, Z.; Ramanadham, S.; Wohltmann, M.; Bohrer, A.; Hsu, F. F.; Turk, J. Studies of insulin secretory responses and of arachidonic acid incorporation into phospholipids of stably transfected insulinoma cells that overexpress group VIA phospholipase A2 (iPLA2β) indicate a signaling rather than a housekeeping role for iPLA2β. J. Biol. Chem. 2001, 276, 13198-13208.
9. 2+ sensitization of contraction in vascular smooth muscle. J. Biol. Chem. 2003, 278, 1856-1863.
10. Jenkins, C. M.; Han, X.; Mancuso, D. J.; Gross, R. W. Identification of calcium-independent phospholipase A2 (iPLA2)β, and not iPLA2γ, as the mediator of arginine vasopressin-induced arachidonic acid release in A-10 smooth muscle cells. Enantioselective mechanism-based discrimination of mammalian iPLA2s. J. Biol. Chem. 2002, 277, 32807-32814.
11. Cummings, B. S.; McHowat, J.; Schnellmann, R. G. Role of an endoplasmic reticulum Ca2+-independent phospholipase A(2) in oxidant-induced renal cell death. Am. J. Physiol 2002, 283, F492-F498.
12. Tang, J.; Kriz, R. W.; Wolfman, N.; Shaffer, M.; Seehra, J.; Jones, S. S. A novel cytosolic calcium-independent phospholipase A2 contains eight ankyrin motifs. J. Biol. Chem. 1997, 272, 8567-8575.
13. 2γ). Biochem. Biophys. Res. Commun. 2004, 320, 1284-1290.
14. 2. Biochim. Biophys. Acta. 1993, 1167, 272-280.
15. 2. J. Biol. Chem. 1994, 269, 23250-23254.
16. 2. Biochemistry 1996, 35, 3712-3721.
17. 2. J. Biol. Chem. 1996, 271, 19225-19231.
18. 2 reveals a novel topology and catalytic mechanism. Cell 1999, 97, 349-360.
19. 2. Biochim. Biophys. Acta 2000, 1488, 40-47.
20. Rydel, T. J.; Williams, J. M.; Krieger, E.; Moshiri, F.; Stallings, W. C.; Brown, S. M.; Pershings, J. C.; Purcell, J. P.; Alibhai, M. F. The crystal structure, mutagenesis, and activity studies reveal that palatin is a lipid acyl hydrolase with a Ser-Asp catalytic dyad. Biochemistry 2003, 42, 6696-6708.
21. 2 inhibitors. J. Biol. Chem. 2003, 278, 41326-41332.
22. 2 by bromoenol lactone and trifluoromethyl ketones. J. Biol. Chem. 1995, 270, 445-450.
23. Street, I. P.; Lin, H. K.; Laliberte, F.; Ghomashchi, F.; Wang, Z.; Perrier, H.; Tremblay, N. M.; Huang, Z.; Weech, P. K.; Gelb, M. H. Slow- and tight-binding inhibitors of the 85-kDa human phospholipase A2. Biochemistry 1993, 32, 5935-5940.
24. 2 by methyl arachidonyl fluorophosphonate. Biochim. Biophys. Acta 1996, 1302, 55-60.
25. 2: structure-function studies with vesicle, micelle, and membrane assays. Biochim. Biophys. Acta 1999, 1420, 45-56.
26. Balsinde, J.; Balboa, M. A.; Insel, P. A.; Dennis, E. A. Regulation and inhibition of phospholipase A(2). Annu. Rev. Pharmacol Toxicol. 1999, 39, 175-189.
27. Balsinde, J.; Dennis, E. A. Bromoenol lactone inhibits magnesium-dependent phosphatidate phosphohydrolase and blocks triacylglycerol biosynthesis in mouse P388D(1) macrophages. J. Biol. Chem. 1996, 271, 31937-31941.
28. Kokotos, G.; Kotsovolou, S.; Six, D. A.; Constantinou-Kokotou, V.; Beltzner, C. C.; Dennis, E. A. Novel 2-oxoamide inhibitors of human Group IV A phospholipase A2. J. Med. Chem. 2002, 45, 2891-2893.
29. Kokotos, G.; Six, D. A.; Loukas, V.; Smith, T.; Constantinou-Kokotou, V.; Hadjipavlou-Litina, D.; Kotsovolou, S.; Chiou, A.; Beltzner, C. C.; Dennis, E. A. Inhibition of Group IV A cytosolic phospholipase A2 by novel 2-oxoamides in vitro, in cells and in vivo. J. Med. Chem. 2004, 47, 3615-3628.
30. Kokotos, G. Inhibition of digestive lipases by 2-oxo amide triacylglycerol analogues. J. Mol. Catal. B: Enzym. 2003, 22, 255-269.
31. Chiou, A.; Verger, R.; Kokotos, G. Synthetic routes and lipase-inhibiting activity of long chain α-keto amides. Lipids 2001, 36, 535-542.
32. Chiou, A.; Markidis, T.; Constantinou-Kokotou, V.; Verger, R.; Kokotos, G. Synthesis and study of a lipophilic α-keto amide inhibitor of pancreatic lipase. Org. Lett. 2000, 2, 347-350.
33. Kotsovolou, S.; Chiou, A.; Verger, R.; Kokotos, G. Bis-2-oxo amide triacylglycerol analogues: a novel class of potent human gastric lipase inhibitors. J. Org. Chem. 2001, 66, 962-967.
34. Kokotos, G.; Verger, R.; Chiou, A. Synthesis of 2-oxo amide triacylglycerol analogues and study of their inhibition effect on pancreatic and gastric lipases. Chem.-Eur. J. 2000, 6, 4211-4217.
35. Kotsovolou, S.; Verger, R.; Kokotos, G. Synthesis of lipophilic aldehydes and study of their inhibition effect on human digestive lipases. Org. Lett. 2002, 4, 2625-2628.
36. Kokotos, G.; Kotsovolou, S.; Verger, R. Novel trifluoromethyl ketones as potent gastric lipase inhibitors. ChemBioChem 2003, 4, 90-95.
37. Dess, D. B.; Martin, J. C. A useful 12-I-5 triacetoxyperiodinane (the Dess-Martin periodinane) for the selective oxidation of primary or secondary alcohols and a variety of related 12-I-5 species. J. Am. Chem. Soc. 1991, 113, 7277-7287.
38. Deems, R. A. Interfacial enzyme kinetics at the phospholipid/water interface: practical considerations. Anal. Biochem. 2000, 287, 1-16.
39. Homan, R.; Hamelehle, K. L. Influence of membrane partitioning on inhibitors of membrane-bound enzymes. J. Pharm. Sci. 2001, 90, 1859-1867.
40. Seno, K.; Okuno, T.; Nishi, K.; Murakami, Y.; Watanabe, F.; Matsuura, T.; Wada, M.; Fujii, Y.; Yamada, M.; Ogawa, T.; Okada, T.; Hashizume, H.; Ku, M.; Hara, S.; Hagishita, S.; Nakamoto, S.; Yamada, K.; Chikazawa, Y.; Ueno, M.; Teshirogi, I.; Ono, T.; Ohtani, M. Pyrrolidine inhibitors of human cytosolic phospholipase A(2). J. Med. Chem. 2000, 43, 1041-1044.
41. Ono, T.; Yamada, K.; Chikazawa, Y.; Ueno, M.; Nakamoto, S.; Okuno, T.; Seno, K. Characterization of a novel inhibitor of cytosolic phospholipase A2α, pyrrophenone. Biochem. J. 2002, 363, 727-735.
42. Ghomashchi, F.; Stewart, A.; Hefner, Y.; Ramanadham, S.; Turk, J.; Leslie, C. C.; Gelb, M. H. A pyrrolidine-based specific inhibitor of cytosolic phospholipase A(2)α blocks arachidonic acid release in a variety of mammalian cells. Biochim. Biophys. Acta 2001, 1513, 160-166.
43. Raschke, W. C.; Baird, S.; Ralph, P.; Nakoinz, I. Functional macrophage cell lines transformed by Ableson leukemia virus. Cell 1978, 15, 261-267.
44. 2s. J. Biol Chem. 1999, 274, 12263-12268.
45. Gijon, M. A.; Leslie, C. C. Regulation of arachidonic acid release and cytosolic phospholipase A2 activation. J. Leukocyte Biol. 1999, 65, 330-336.
46. Yang, H. C.; Mosior, M.; Johnson, C. A.; Chen, Y.; Dennis, E. A. Group-specific assays that distinguish between the four major types of mammalian phospholipase A2. Anal. Biochem. 1999, 269, 278-288.
47. Lucas, K. K.; Svensson, C. I.; Hua, X. Y.; Yaksh, T. L.; Dennis, E. A. Spinal phospholipase A2 in inflammatory hyperalgesia: role of Group IV A cPLA2. Br. J. Pharmacol 2005, 144, 940-952.
48. Reynolds, L. J.; Washburn, W. N.; Deems, R. A.; Dennis, E. A. Assay strategies and methods for phospholipases. Methods Enzymol. 1991, 797, 3-23.